Identification of a Zn2+-binding site on the dopamine D2 receptor

被引:19
作者
Liu, Y
Teeter, MM
DuRand, CJ
Neve, KA [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA
[2] Portland Vet Affairs Med Ctr, Portland, OR 97239 USA
[3] Univ Calif Davis, Dept Psychiat, Davis, CA 95616 USA
[4] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA
[5] Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA
关键词
allosteric modulation; zinc ion-binding site; dopamine D-2 receptor; site-directed mutagenesis;
D O I
10.1016/j.bbrc.2005.11.110
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Zinc (II) modulates the function of many integral membrane proteins. To identify the Zn2+-binding site responsible for allosteric modulation of the D-2 dopamine receptor, we first demonstrated that the binding site is likely located in extracellular loops or in transmembrane regions that are accessible from the extracellular milieu. We mutated every histidine in these regions to alanine; two mutants, H394A and H399A, exhibited a reduced response to Zn2+. Combined mutation of H394 and H399 caused a larger effect of zinc than did either single mutation. Mutation of other potential Zn2+-binding residues predicted to be in proximity to H394 or H399 did not substantially alter the potency of Zn2+. The double mutant H394A/H399A was similar to D-2 in affinity for [H-3]spiperone and ability to inhibit cyclic AMP accumulation. We conclude that binding of Zn2+ to H394 and H399 on the dopamine D, receptor contributes to allosteric regulation of antagonist binding. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:873 / 879
页数:7
相关论文
共 38 条
[1]   CURRENT STATUS OF ZINC IN HEALTH AND DISEASE STATES [J].
AGGETT, PJ ;
HARRIES, JT .
ARCHIVES OF DISEASE IN CHILDHOOD, 1979, 54 (12) :909-917
[2]   RELEASE OF ENDOGENOUS ZN-2+ FROM BRAIN-TISSUE DURING ACTIVITY [J].
ASSAF, SY ;
CHUNG, SH .
NATURE, 1984, 308 (5961) :734-736
[3]   The galvanization of biology: A growing appreciation for the roles of zinc [J].
Berg, JM ;
Shi, YG .
SCIENCE, 1996, 271 (5252) :1081-1085
[4]   THE ALLOSTERIC ENHANCER, PD-81,723, STABILIZES HUMAN A(1)-ADENOSINE RECEPTOR COUPLING TO G-PROTEINS [J].
BHATTACHARYA, S ;
LINDEN, J .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1995, 1265 (01) :15-21
[5]   X-RAY-ANALYSIS (1.4-A RESOLUTION) OF AVIAN PANCREATIC-POLYPEPTIDE - SMALL GLOBULAR PROTEIN HORMONE [J].
BLUNDELL, TL ;
PITTS, JE ;
TICKLE, IJ ;
WOOD, SP ;
WU, CW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (07) :4175-4179
[6]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]   Conversion of agonist site to metal-ion chelator site in the β2-adrenergic receptor [J].
Elling, CE ;
Thirstrup, K ;
Holst, B ;
Schwartz, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12322-12327
[8]   Refinement of a homology model of the μ-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites [J].
Fowler, CB ;
Pogozheva, ID ;
LeVine, H ;
Mosberg, HI .
BIOCHEMISTRY, 2004, 43 (27) :8700-8710
[9]   Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors [J].
Gnagey, AL ;
Seidenberg, M ;
Ellis, J .
MOLECULAR PHARMACOLOGY, 1999, 56 (06) :1245-1253
[10]  
HANAS JS, 1983, J BIOL CHEM, V258, P4120